Advertisement

Topics

PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections

2014-08-26 22:33:34 | BioPortfolio

Summary

Primary

- To evaluate the efficacy of Pulmonaron in the decrease of interleukin-4/interferon gamma after second period of treatment

Secondary

- To evaluate the efficacy of Pulmonarom in the prevention of upper respiratory tract infections symptoms through patient evaluation of fever or respiratory presence after second period of treatment

- To evaluate loss of working or study days after second period of treatment

- To evaluate the safety and tolerability of Pulmonarom in the population under study

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Respiratory Tract Infections

Intervention

Bacterial Lysates, placebo

Location

Sanofi-Aventis Administrative Office
Col. Coyoacan
Mexico

Status

Completed

Source

Sanofi-Aventis

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-26T22:33:34-0400

Clinical Trials [1245 Associated Clinical Trials listed on BioPortfolio]

Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections

To assess effectiveness of Trulimax (Azithromycin) in Acute Bacterial Upper Respiratory Tract Infections (URTIs).

Outpatient Registry Trial of Respiratory Tract Infections in Adults

To measure the speed of bacterial eradication from the respiratory tract after administration of azithromycin or telithromycin.

A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections

The specific objectives of this investigation are to assess the effectiveness of daily gargling and vitamin D supplementation as preventative measures against incident upper respiratory tr...

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

RSV infections can develop into serious, life threatening conditions among immunocompromised patients. The objective of this study (ADMA 001) is to evaluate the safety and efficacy of RI-...

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study

The purpose of this study is to assess the efficacy and safety of J022X ST for prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) compared to placebo in children of younger...

PubMed Articles [10867 Associated PubMed Articles listed on BioPortfolio]

Mechanisms of Bacterial Colonization of the Respiratory Tract.

Respiratory tract infections are an important cause of morbidity and mortality worldwide. Chief among these are infections involving the lower airways. The opportunistic bacterial pathogens responsibl...

Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus.

In order to improve clinical management and prevention of viral infections in hospitalised children improved etiological insight is needed. The aim of the present study was to assess the spectrum of r...

Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus.

Most respiratory tract infections are self-limiting and caused by viruses, and do not warrant antibiotic treatment. Despite this, patients with respiratory tract infections often receive antibiotics, ...

Antibiotic use for viral acute respiratory tract infections remains common.

To determine the type and number of antibiotic prescriptions filled in the 28 days following an index visit for acute respiratory tract infections (ARTIs) generally presumed to be viral.

Many children aged two to five years old have a persistent presence of respiratory viruses in their nasopharynx.

On average, young children have six to eight viral respiratory infections (VRI) per year (1). This high prevalence, combined with the ease of spread in the community, makes VRI the most common reason ...

Medical and Biotech [MESH] Definitions

A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.

The expelling of bacteria from the body. Important routes include the respiratory tract, genital tract, and intestinal tract.

Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.

Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.

An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.

More From BioPortfolio on "PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections"

Quick Search
Advertisement
 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...